Have not been on this site in a few weeks! I am going to start working on it again I think! Anyone willing to help please email me and we can discuss it!



You can also find me on facebook, under my name, Carol Rains

My husband John Rains is always willing to talk to any caregivers… Continue

Just wanted to take a minute, and drop you all a note! See if anyone has any plans for the SUMMER????



Does your pain increase or decrease, or does it stay the same in the summer months? 



Is anyone planning on… Continue

Improving Recognition and Care for Fibromyalgia by Will Rowe Friday, February 20, 2009 The Food and Drug Administration recently approved a third drug indicated for treatment of fibromyalgia. Milnacipran, made by Forest Laboratories and Cypres Bioscience, is a selective serotonin and norepinephrine dual reuptake inhibitor. It will be available to consumers in March. The two other medicines approved by the FDA for fibromyalgia are Lyrica, produced by Pfizer, and Cymbalta, produced by Lilly. From… Continue

New FDA Scrutiny on Pain Medications by Will Rowe Wednesday, February 25, 2009 The FDA has a very tough job. With respect to medicines, they require and examine documents that attempt to demonstrate that proposed medicines are safe AND effective. This is part of the approval (FDA –Approved) process. Now, since the new FDA Amendments Act, they have to monitor and implement safety measures for medicines after the approval process. They have to monitor and require safety plans for after medicines… Continue

Pain Sensitivity Increases With Opioids Treatment 19 Mar 2009 Use of opioid pain medications may contribute to an increase in sensitivity to some types of pain, according to an Australian study published in The Journal of Pain. Researchers sought to examine the effect of long-term opioid use in chronic noncancer pain patients and opioid-maintained patients to determine if the medications can cause hyperalgesia or allydonia. They examined three groups of subjects: chronic pain patients receiving… Continue

The Patient Advocate Foundation



http://www.copays.org/





The Patient Advocate Foundation (PAF) Co-Pay Relief Program (CPR) currently provides direct financial support to insured patients, including Medicare Part D beneficiaries, who must financially and medically qualify to access pharmaceutical co-payment assistance. The program offers personal service to… Continue